The real-world safety and effectiveness of ocrelizumab in patients with relapsing multiple sclerosis - a confidence study interim analysis
MULTIPLE SCLEROSIS JOURNAL(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
MULTIPLE SCLEROSIS JOURNAL(2022)